LCE3E
gene geneOn this page
Also known as LEP17
Summary
LCE3E (late cornified envelope 3E, HGNC:29463) is a protein-coding gene on chromosome 1q21.3, encoding Late cornified envelope protein 3E (Q5T5B0). Precursors of the cornified envelope of the stratum corneum.
Predicted to be involved in keratinization.
Source: NCBI Gene 353145 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_178435
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29463 |
| Approved symbol | LCE3E |
| Name | late cornified envelope 3E |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LEP17 |
| Ensembl gene | ENSG00000185966 |
| Ensembl biotype | protein_coding |
| OMIM | 612617 |
| Entrez | 353145 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000368789
RefSeq mRNA: 1 — MANE Select: NM_178435
NM_178435
CCDS: CCDS1013
Canonical transcript exons
ENST00000368789 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001447963 | 152565654 | 152566229 |
| ENSE00001447964 | 152566738 | 152566780 |
Expression profiles
Bgee: expression breadth broad, 35 present calls, max score 78.39.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1828 / max 36.6043, expressed in 34 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14565 | 0.1828 | 34 |
Top tissues by expression
97 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 78.39 | gold quality |
| zone of skin | UBERON:0000014 | 75.37 | gold quality |
| skin of abdomen | UBERON:0001416 | 71.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.21 | gold quality |
| esophagus mucosa | UBERON:0002469 | 67.19 | gold quality |
| vagina | UBERON:0000996 | 58.36 | gold quality |
| ectocervix | UBERON:0012249 | 55.67 | gold quality |
| tonsil | UBERON:0002372 | 51.58 | gold quality |
| esophagus | UBERON:0001043 | 47.04 | gold quality |
| uterine cervix | UBERON:0000002 | 45.67 | gold quality |
| granulocyte | CL:0000094 | 40.14 | gold quality |
| sural nerve | UBERON:0015488 | 37.56 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 36.31 | silver quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| minor salivary gland | UBERON:0001830 | 34.91 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 34.40 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| right uterine tube | UBERON:0001302 | 32.34 | gold quality |
| right coronary artery | UBERON:0001625 | 32.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.30 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| multicellular organism | UBERON:0000468 | 28.99 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting LCE3E, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-486-5P | 99.51 | 70.39 | 707 |
| HSA-MIR-6878-3P | 99.24 | 64.23 | 920 |
| HSA-MIR-6744-3P | 99.22 | 64.41 | 972 |
| HSA-MIR-4757-5P | 99.12 | 64.51 | 981 |
| HSA-MIR-6811-3P | 98.62 | 66.54 | 944 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-4691-5P | 98.41 | 66.77 | 1343 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-212-5P | 96.83 | 67.43 | 950 |
| HSA-MIR-6854-5P | 96.77 | 65.96 | 848 |
Literature-anchored findings (GeneRIF, showing 1)
- paper describing nomenclature changes and expression in range of tissues and in response to UV (PMID:15854049)
Cross-species orthologs
0 orthologs
Paralogs (20): LCE2B (ENSG00000159455), SPRR2G (ENSG00000159516), LCE3D (ENSG00000163202), SPRR3 (ENSG00000163209), SPRR1B (ENSG00000169469), SPRR1A (ENSG00000169474), LCE1D (ENSG00000172155), SPRR4 (ENSG00000184148), LCE3A (ENSG00000185962), LCE5A (ENSG00000186207), LCE1E (ENSG00000186226), LCE2A (ENSG00000187173), LCE2C (ENSG00000187180), LCE2D (ENSG00000187223), LCE3B (ENSG00000187238), KPLCE (ENSG00000198854), PRR9 (ENSG00000203783), LELP1 (ENSG00000203784), LCE1F (ENSG00000240386), LCE3C (ENSG00000244057)
Protein
Protein identifiers
Late cornified envelope protein 3E — Q5T5B0 (reviewed: Q5T5B0)
Alternative names: Late envelope protein 17
All UniProt accessions (1): Q5T5B0
UniProt curated annotations — full annotation on UniProt →
Function. Precursors of the cornified envelope of the stratum corneum.
Subunit / interactions. Interacts with CYSRT1.
Tissue specificity. Skin-specific. Expression was readily detected in adult trunk skin, adult arm skin, fetal skin, penal skin, vulva, esophagus and tongue. Not expressed in the cervix, rectum, lung, colon, or placenta.
Induction. By UVB.
Miscellaneous. Belongs to the LCE cluster present on 1q21.
Similarity. Belongs to the LCE family.
RefSeq proteins (1): NP_848522* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028205 | LCE | Family |
Pfam: PF14672
UniProt features (6 total): compositionally biased region 3, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T5B0-F1 | 59.34 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 13 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, chr1q21, CAMPS_COLON_CANCER_COPY_NUMBER_DN, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE, GOBP_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_DIFFERENTIATION, MIR486_5P, MIR6878_3P
GO Biological Process (2): keratinization (GO:0031424), epidermis development (GO:0008544)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Keratinization | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| tissue development | 1 |
| binding | 1 |
Protein interactions and networks
STRING
332 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LCE3E | LCE2C | Q5TA81 | 785 |
| LCE3E | LCE2D | Q5TA82 | 761 |
| LCE3E | LCE1C | Q5T751 | 757 |
| LCE3E | SPRR2A | P35326 | 745 |
| LCE3E | SPRR2D | P22532 | 719 |
| LCE3E | SPRR2G | Q9BYE4 | 638 |
| LCE3E | LCE1E | Q5T753 | 627 |
| LCE3E | SPRR2E | P22531 | 620 |
| LCE3E | LCE2A | Q5TA79 | 620 |
| LCE3E | LCE1F | Q5T754 | 596 |
| LCE3E | LCE2B | O14633 | 595 |
| LCE3E | CDSN | Q15517 | 579 |
| LCE3E | LCE1B | Q5T7P3 | 578 |
| LCE3E | LCE1A | Q5T7P2 | 577 |
| LCE3E | LCE6A | A0A183 | 571 |
IntAct
224 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-9 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.740 |
| LCE3E | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.740 |
| LCE3E | RGS20 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-7 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-8 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
| ADAMTSL4 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | MDFI | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP4-12 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP4-2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP5-9 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.720 |
| LCE3E | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MDFI | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP9-2 | LCE3E | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (72): LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), LCE3E (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTR4, A6QNZ4, O14633, O70554, O70555, O70556, O70557, O70558, O70559, O70560, O70562, P15265, P22528, P22531, P22532, P35321, P35322, P35323, P35324, P35325, P35326, P49901, Q28658, Q32L04, Q4KL71, Q4R956, Q5T5B0, Q5T750, Q5T752, Q5T754, Q5T870, Q5T871, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q62266
Diamond homologs: O14633, Q5T5A8, Q5T5B0, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q9BYE3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 49 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 28 | 38.0× | 1e-38 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| hair cycle | 5 | 167.2× | 1e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
144 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:152566734:TTAC:T | donor_loss | 0.9900 |
| 1:152566735:TAC:T | donor_loss | 0.9900 |
| 1:152566736:ACC:A | donor_loss | 0.9900 |
| 1:152566736:A:AC | donor_gain | 0.9800 |
| 1:152566737:C:CG | donor_gain | 0.9800 |
| 1:152566737:CCA:C | donor_gain | 0.9800 |
| 1:152566737:CCAG:C | donor_gain | 0.9800 |
| 1:152566736:AC:A | donor_gain | 0.9700 |
| 1:152566737:CC:C | donor_gain | 0.9700 |
| 1:152566737:CCAGG:C | donor_gain | 0.9600 |
| 1:152566230:C:CC | acceptor_gain | 0.9500 |
| 1:152566226:TGTC:T | acceptor_gain | 0.9400 |
| 1:152566227:GTCC:G | acceptor_loss | 0.9400 |
| 1:152566228:TCCT:T | acceptor_loss | 0.9400 |
| 1:152566229:CCTG:C | acceptor_loss | 0.9400 |
| 1:152566230:CT:C | acceptor_loss | 0.9400 |
| 1:152566231:T:C | acceptor_loss | 0.9400 |
| 1:152566732:ACTT:A | donor_loss | 0.8600 |
| 1:152566232:G:C | acceptor_loss | 0.8500 |
| 1:152566241:G:T | acceptor_loss | 0.8200 |
| 1:152566240:C:CT | acceptor_loss | 0.8000 |
| 1:152566227:GTC:G | acceptor_gain | 0.7900 |
| 1:152566228:TC:T | acceptor_gain | 0.7800 |
| 1:152566229:CC:C | acceptor_gain | 0.7800 |
| 1:152566309:C:CC | acceptor_gain | 0.7800 |
| 1:152566235:GAAAA:G | acceptor_loss | 0.7700 |
| 1:152566308:GCTGC:G | acceptor_gain | 0.7500 |
| 1:152566305:AGAG:A | acceptor_gain | 0.6800 |
| 1:152566306:GAG:G | acceptor_gain | 0.6700 |
| 1:152566307:AGCTG:A | acceptor_gain | 0.6500 |
AlphaMissense
598 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:152566163:A:G | C16R | 0.625 |
| 1:152566055:A:G | C52R | 0.581 |
| 1:152566161:G:C | C16W | 0.576 |
dbSNP variants (sampled 300 via entrez): RS1000760942 (1:152567527 T>G), RS1000815293 (1:152567248 G>C), RS1001269955 (1:152565226 T>C), RS1001369010 (1:152567404 C>CT), RS1002310908 (1:152567068 T>A,C), RS1002871762 (1:152568126 G>A), RS1002925752 (1:152567660 G>A), RS1003317486 (1:152565796 A>G), RS1004833546 (1:152568564 A>G,T), RS1006174832 (1:152567832 T>C), RS1006836833 (1:152565207 C>A,T), RS1007180366 (1:152566439 C>A,T), RS1008054850 (1:152567209 G>A), RS1009514040 (1:152568031 G>A), RS1010408438 (1:152568424 G>A,C)
Disease associations
OMIM: gene MIM:612617 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000706_14 | Common traits (Other) | 1.000000e-10 |
| GCST002740_3 | Inflammatory skin disease | 5.000000e-25 |
| GCST003184_30 | Atopic dermatitis | 6.000000e-29 |
| GCST005005_6 | Plantar warts | 5.000000e-09 |
| GCST007563_33 | Allergic disease (asthma, hay fever or eczema) | 3.000000e-11 |
| GCST007564_24 | Asthma or allergic disease (pleiotropy) | 5.000000e-12 |
| GCST008479_3 | Psoriasis | 6.000000e-11 |
| GCST008479_32 | Psoriasis | 6.000000e-13 |
| GCST008479_4 | Psoriasis | 2.000000e-08 |
| GCST008916_82 | Asthma | 5.000000e-27 |
| GCST008916_88 | Asthma | 1.000000e-25 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005038 | hair morphology |
| EFO:0008406 | susceptibility to plantar warts measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | increases expression | 3 |
| sodium arsenite | increases expression | 2 |
| Benzo(a)pyrene | affects expression, increases methylation | 2 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| pentanal | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Nanotubes, Carbon | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): atopic eczema